Yan‐Feng Ouyang

Hyperfractionation compared with standard fractionation in intensity-modulated radiotherapy for patients with locally advanced recurrent nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial

Rui You, You‐Ping Liu, Yu‐Long Xie et al. · The Lancet · 2023 · 104 citations

Medicine, Oncology, Radiation Oncology +16

Camrelizumab Plus Apatinib in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma: An Open-Label, Single-Arm, Phase II Study

Xi Ding, Weijing Zhang, Rui You et al. · Journal of Clinical Oncology · 2023 · 70 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Toripalimab plus intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma: an open-label single-arm, phase II trial

Yi‐Jun Hua, Rui You, Zhiqiang Wang et al. · Journal for ImmunoTherapy of Cancer · 2021 · 40 citations · Full text

Medicine, Oncology, Radiation Oncology +14

Efficacy of local therapy to metastatic foci in nasopharyngeal carcinoma: large-cohort strictly-matched retrospective study

Mengxia Zhang, Ting Liu, Rui You et al. · Therapeutic Advances in Medical Oncology · 2022 · 24 citations · Full text

Medicine, Biostatistics, Oncology +16

Camrelizumab plus famitinib in patients with recurrent or metastatic nasopharyngeal carcinoma treated with PD-1 blockade: data from a multicohort phase 2 study

Xi Ding, Yi‐Jun Hua, Xiong Zou et al. · EClinicalMedicine · 2023 · 23 citations · Full text

Medicine, Oncology, Pharmacology +17